172 related articles for article (PubMed ID: 32380900)
1. Metastatic penile squamous cell carcinoma with dramatic response to combined checkpoint blockade with ipilimumab and nivolumab.
Baweja A; Mar N
J Oncol Pharm Pract; 2021 Jan; 27(1):212-215. PubMed ID: 32380900
[TBL] [Abstract][Full Text] [Related]
2. [Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report].
Kubota Y; Nakano M; Nagai S; Matsuoka K; Arakawa H; Horie K; Deguchi T; Kato H
Hinyokika Kiyo; 2015 Jan; 61(1):33-7. PubMed ID: 25656018
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis.
Xu J; Li G; Zhu SM; Cai QL; Wang Z; Yang X; Zhang HT; Niu YJ
BMC Cancer; 2019 Jun; 19(1):625. PubMed ID: 31238987
[TBL] [Abstract][Full Text] [Related]
4. A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).
Meindl-Beinker NM; Betge J; Gutting T; Burgermeister E; Belle S; Zhan T; Schulte N; Maenz M; Ebert MP; Haertel N
BMC Cancer; 2019 Mar; 19(1):231. PubMed ID: 30871493
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.
Pagliaro LC; Williams DL; Daliani D; Williams MB; Osai W; Kincaid M; Wen S; Thall PF; Pettaway CA
J Clin Oncol; 2010 Aug; 28(24):3851-7. PubMed ID: 20625118
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
El Zarif T; Nassar AH; Pond GR; Zhuang TZ; Master V; Nazha B; Niglio S; Simon N; Hahn AW; Pettaway CA; Tu SM; Abdel-Wahab N; Velev M; Flippot R; Buti S; Maruzzo M; Mittra A; Gheeya J; Yang Y; Rodriguez PA; Castellano D; de Velasco G; Roviello G; Antonuzzo L; McKay RR; Vincenzi B; Cortellini A; Hui G; Drakaki A; Glover M; Khaki AR; El-Am E; Adra N; Mouhieddine TH; Patel V; Piedra A; Gernone A; Davis NB; Matthews H; Harrison MR; Kanesvaran R; Giudice GC; Barata P; Farolfi A; Lee JL; Milowsky MI; Stahlfeld C; Appleman L; Kim JW; Freeman D; Choueiri TK; Spiess PE; Necchi A; Apolo AB; Sonpavde GP
J Natl Cancer Inst; 2023 Dec; 115(12):1605-1615. PubMed ID: 37563779
[TBL] [Abstract][Full Text] [Related]
7. Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.
Winer A; Ghatalia P; Bubes N; Anari F; Varshavsky A; Kasireddy V; Liu Y; El-Deiry WS
Oncologist; 2019 Nov; 24(11):1416-1419. PubMed ID: 31444293
[TBL] [Abstract][Full Text] [Related]
8. Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report.
Fuu T; Iijima K; Kusama Y; Otsuki T; Kato H
J Med Case Rep; 2022 May; 16(1):193. PubMed ID: 35581611
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.
Zhang S; Zhu Y; Ye D
Oncotarget; 2015 Oct; 6(31):32212-9. PubMed ID: 26311739
[TBL] [Abstract][Full Text] [Related]
10. Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer.
Morse MA; Overman MJ; Hartman L; Khoukaz T; Brutcher E; Lenz HJ; Atasoy A; Shangguan T; Zhao H; El-Rayes B
Oncologist; 2019 Nov; 24(11):1453-1461. PubMed ID: 31147488
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy.
Necchi A; Lo Vullo S; Nicolai N; Raggi D; Giannatempo P; Colecchia M; Catanzaro M; Torelli T; Piva L; Biasoni D; Stagni S; Mariani L; Salvioni R
Clin Genitourin Cancer; 2016 Dec; 14(6):518-523. PubMed ID: 27050716
[TBL] [Abstract][Full Text] [Related]
12. Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients.
Trager MH; Coley SM; Dube G; Khan S; Ingham M; Samie FH; Geskin LJ; McDonnell D; Brouder D; Saenger Y; Carvajal R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503950
[TBL] [Abstract][Full Text] [Related]
13. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.
Lissoni AA; Colombo N; Pellegrino A; Parma G; Zola P; Katsaros D; Chiari S; Buda A; Landoni F; Peiretti M; Dell'anna T; Fruscio R; Signorelli M; Grassi R; Floriani I; Fossati R; Torri V; Rulli E
Ann Oncol; 2009 Apr; 20(4):660-5. PubMed ID: 19181826
[TBL] [Abstract][Full Text] [Related]
14. BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer.
Epaillard N; Simonaggio A; Elaidi R; Azzouz F; Braychenko E; Thibault C; Sun CM; Moreira M; Oudard S; Vano YA
Bull Cancer; 2020 Jun; 107(5S):eS22-eS27. PubMed ID: 32620212
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy with cetuximab for locally advanced penile cancer.
Luo WX; He JP; Li X; Liu JY
J Cancer Res Ther; 2015; 11(4):1041. PubMed ID: 26881664
[No Abstract] [Full Text] [Related]
16. A new neoadjuvant chemotherapy regimen for penile cancer with nodal metastases: a step forward.
Hakenberg OW
Eur Urol; 2009 Mar; 55(3):552-3; discussion 554-5. PubMed ID: 19062154
[No Abstract] [Full Text] [Related]
17. A case of penile squamous cell carcinoma treated with a combination of antiepidermal growth factor receptor antibody and chemotherapy.
Men HT; Gou HF; Qiu M; He JP; Cheng K; Chen Y; Ge J; Liu JY
Anticancer Drugs; 2014 Jan; 25(1):123-5. PubMed ID: 24263192
[TBL] [Abstract][Full Text] [Related]
18. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G
J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913
[TBL] [Abstract][Full Text] [Related]
19. Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.
Necchi A; Eigl BJ; Yang ES; Bae S; Chandrashekar D; Chen D; Naik G; Mehta A; Giannatempo P; Colecchia M; Gordetsky J; Wei S; Cooper T; Varambally S; Sonpavde G
Eur Urol Focus; 2018 Sep; 4(5):733-736. PubMed ID: 28753783
[TBL] [Abstract][Full Text] [Related]
20. Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma.
Trafalis DT; Alifieris CE; Kalantzis A; Verigos KE; Vergadis C; Sauvage S
J Immunother; 2018; 41(6):300-305. PubMed ID: 29642086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
